EXTH-01. MODELING THE SAFETY OF TOPICAL AGENTS FOR SKIN TOXICITY ASSOCIATED WITH TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA

Por Lacouture, Mario, Hershkovich, Hadas, Giladi, Moshe, Bomzon, Zeev, Kirson, Eilon, Weinberg, Uri, Plati, Yoram
Publicado no Neuro Oncol (2018)

ROLE OF TARGETED THERAPY IN THE COMBINATION TREATMENT OF PATIENTS WITH KIDNEY CANCER AND METASTATIC BRAIN INVOLVEMENT

Por D. R. Naskhletashvili, V. A. Gorbunova, A. Kh. Bekyashev, V. B. Karakhan, E. A. Moskvina, E. V. Prozorenko
Publicado em 2015-04-01

Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide

Por Hardee, Matthew E., Formenti, Silvia C.
Publicado em 2012

CD133(+) brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence

Por Garg, N, Bakhshinyan, D, Venugopal, C, Mahendram, S, Rosa, D A, Vijayakumar, T, Manoranjan, B, Hallett, R, McFarlane, N, Delaney, K H, Kwiecien, J M, Arpin, C C, Lai, P-S, Gómez-Biagi, R F, Ali, A M, de Araujo, E D, Ajani, O A, Hassell, J A, Gunning, P T, Singh, S K
Publicado no Oncogene (2017)

Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment

Por Baker, Jennifer Hazel Elizabeth, Kyle, Alastair Hugh, Reinsberg, Stefan Alexander, Moosvi, Firas, Patrick, Haley Margaret, Cran, Jordan, Saatchi, Katayoun, Häfeli, Urs, Minchinton, Andrew Ivor
Publicado no Clin Exp Metastasis (2018)

P04.59 Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma

Por Lacouture, M, Hershkovich, H, Giladi, M, Blat, R, Bomzon, Z, Kirson, E, Weinberg, U, Palti, Y
Publicado no Neuro Oncol (2018)

Brain metastases from stomach cancer – The role of different treatment modalities and efficacy of palliative radiotherapy

Por Kraszkiewicz, Malgorzata, Wydmanski, Jerzy
Publicado no Rep Pract Oncol Radiother (2014)

P10.03 The prognostic role of primary treatment in pediatric High-Grade Gliomas: the experience at Meyer Children’s Hospital

Por Lucchesi, M., Scoccianti, S., Guidi, M., Facchini, L., Farina, S., Fonte, C., Favre, C., Genitori, L., Sardi, I.
Publicado no Neuro Oncol (2016)

Three Paths to Better Tyrosine Kinase Inhibition Behind the Blood-Brain Barrier in Treating Chronic Myelogenous Leukemia and Glioblastoma with Imatinib

Por Kast, Richard E, Focosi, Daniele
Publicado em 2010

Disruption of White Matter Integrity in Adult Survivors of Childhood Brain Tumors: Correlates with Long-Term Intellectual Outcomes.

Por Tricia Z King, Liya Wang, Hui Mao
Publicado em 2015-01-01

Disruption of White Matter Integrity in Adult Survivors of Childhood Brain Tumors: Correlates with Long-Term Intellectual Outcomes

Por King, Tricia Z., Wang, Liya, Mao, Hui
Publicado no PLoS One (2015)

microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis

Por Bhere, Deepak, Tamura, Kaoru, Wakimoto, Hiroaki, Choi, Sung Hugh, Purow, Benjamin, Debatisse, Jeremy, Shah, Khalid
Publicado no Neuro Oncol (2018)

Monitoring Brain Tumor Vascular Heamodynamic following Anti-Angiogenic Therapy with Advanced Magnetic Resonance Imaging in Mice

Por Laufer, Shlomi, Mazuz, Ahinoam, Nachmansson, Nathalie, Fellig, Yakov, Corn, Benjamin William, Bokstein, Felix, Bashat, Dafna Ben, Abramovitch, Rinat
Publicado no PLoS One (2014)

PT-11 THALAMIC TUMORS IN CHILDREN: THE CURRENT ROLE OF SURGERY IN A MULTIMODAL TREATMENT APPROACH

Por Slavc, Irene, Dorfer, Christian, Haberler, Christine, Chocholous, Monika, Azizi, Amedeo A., Peyrl, Andreas, Dieckmann, Karin, Czech, Thomas
Publicado em 2014

SCDT-11. ASTROCYTIC S1P3 SIGNALING MODULATES BLOOD-TUMOR BARRIER PERMEABILITY IN BRAIN METASTASES

Por Gril, Brunilde, Paranjape, Anurag N, Woditschka, Stephan, Hanson, Jeffrey, Wu, Xiaolin, Duchnowska, Renata, Brastianos, Priscilla K, Peer, Cody, Figg, William D, Pauly, Gary T, Schneider, Joel P, Steeg, Patricia S
Publicado no Neuro Oncol (2017)

TMIC-19. ASTROCYTIC S1P3 SIGNALING MODULATES BLOOD-TUMOR BARRIER PERMEABILITY IN BRAIN METASTASES

Por Gril, Brunilde, Paranjape, Anurag N, Woditschka, Stephan, Hanson, Jeffrey, Wu, Xiaolin, Duchnowska, Renata, Brastianos, Priscilla K, Peer, Cody, Figg, William D, Pauly, Gary T, Schneider, Joel P, Steeg, Patricia
Publicado no Neuro Oncol (2017)

Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts

Por Doloff, Joshua C, Waxman, David J
Publicado no BMC Cancer (2015)

The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth

Por Mélanie Rose, Marie Duhamel, Soulaimane Aboulouard, Firas Kobeissy, Emilie Le Rhun, Annie Desmons, Dominique Tierny, Isabelle Fournier, Franck Rodet, Michel Salzet
Publicado em 2020-06-01

CMET-31. THE ROLE OF SURGERY IN THE COMBINED TREATMENT OF BRAIN METASTASES (BM). TWELVE YEARS NEUROSURGICAL EXPERIENCE

Por Carapella, Carmine, Albanese, Rosalinda, Telera, Stefano, Raus, Laura, Villani, Veronica, Fabi, Alessandra, Pace, Andrea
Publicado no Neuro Oncol (2017)

Compartment-specific roles of ABC transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid

Por Shen, Jun, Carcaboso, Angel M., Hubbard, K. Elaine, Tagen, Michael, Wynn, Henry G., Panetta, John C., Waters, Christopher M., Elmeliegy, Mohamed A., Stewart, Clinton F.
Publicado em 2009